McDaniel Cassidi C, Kavookjian Jan, Whitley Heather P
Department of Health Outcomes Research and Policy, Auburn University Harrison School of Pharmacy, Auburn, AL, USA.
Department of Health Outcomes Research and Policy, Auburn University Harrison School of Pharmacy, Auburn, AL, USA.
Patient Educ Couns. 2022 Apr;105(4):805-820. doi: 10.1016/j.pec.2021.07.036. Epub 2021 Jul 24.
The objective of this systematic review was to explore and report the evidence and gaps in the literature for randomized controlled trials (RCTs) studying the effects of motivational interviewing (MI)-based telehealth interventions on outcomes among persons with diabetes (PWD) or prediabetes.
Following a modified Cochrane approach, we searched Pubmed, CENTRAL, CINAHL, PsycINFO, and Clinicaltrials.gov. Included studies were RCTs published in English before March 25, 2021 evaluating MI-based telehealth on outcomes for adults with diabetes or prediabetes.
A total of 21 retained articles captured results for 6436 PWD. Among the most commonly investigated outcomes, 60% of articles documented A1C reductions (ranging from<1% to>3%), 56% documented systolic blood pressure reductions, 57% documented diabetes self-efficacy/empowerment improvements, and 40% documented physical activity improvements. Conversely, diastolic blood pressure, lipid panels, body mass index, depressive symptoms, and quality of life were frequently measured outcomes, where MI-based telehealth yielded minor effects (<30% of articles demonstrating improvements).
MI-based telehealth seems most effective for improving A1C, systolic blood pressure, diabetes self-efficacy, and physical activity behaviors. Variability in outcome assessment and intervention heterogeneity were key challenges impeding comparisons across retained articles.
MI-based telehealth interventions demonstrate promising results for improving outcomes in PWD.
本系统评价的目的是探索并报告文献中关于随机对照试验(RCT)的证据及差距,这些试验研究了基于动机性访谈(MI)的远程医疗干预对糖尿病患者(PWD)或糖尿病前期患者结局的影响。
遵循改良的Cochrane方法,我们检索了PubMed、CENTRAL、CINAHL、PsycINFO和Clinicaltrials.gov。纳入的研究为2021年3月25日前发表的英文RCT,评估基于MI的远程医疗对成年糖尿病或糖尿病前期患者结局的影响。
总共21篇留存文章涵盖了6436名糖尿病患者的结果。在最常研究的结局中,60%的文章记录了糖化血红蛋白(A1C)降低(范围从<1%至>3%),56%记录了收缩压降低,57%记录了糖尿病自我效能/赋权改善,40%记录了身体活动改善。相反,舒张压、血脂指标、体重指数、抑郁症状和生活质量是经常测量的结局,基于MI的远程医疗产生的影响较小(<30%的文章显示有改善)。
基于MI的远程医疗似乎对改善A1C、收缩压、糖尿病自我效能和身体活动行为最有效。结局评估的变异性和干预的异质性是妨碍对留存文章进行比较的关键挑战。
基于MI的远程医疗干预在改善糖尿病患者结局方面显示出有前景的结果。